newsfilter
← Latest News
PR Newswire·

Calliditas Announces Positive NefIgArd Open Label Extension Results

Calliditas Therapeutics AB (NASDAQ: CALT), (NASDAQ STOCKHOLM: CALTX) ("Calliditas") today announced that the global open-label extension (OLE) study...